Close Menu

Buck Institute

The patent is based on the work of Aelan's founder and covers an epigenetic  biomarker associated with DNA damage, cellular senescence, and aging.

A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

A recent protein interaction study revealed that invertebrates have more in common with humans when it comes to the aging process than had been previously known, and that "the broad patterns underlying genetic control of life span in invertebrates is highly relevant to human aging and longevity."

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.